MARATTO

article · PLOS Global Public Health

Developing a Naïve Bayes risk classification machine learning algorithm to predict high viral load in a low-resource setting

Abstract

Access to routine viral load (VL) testing for people living with HIV (PLHIV) remains limited in many low-resource settings. There is a need for pragmatic, data-driven tools that can proactively identify individuals at increased risk of virological failure. This study aimed to identify predictors of high viral load among PLHIV on antiretroviral therapy (ART) and to evaluate the performance of a Naïve Bayes classification algorithm using routinely collected clinical data. We conducted a retrospective case-control study using secondary clinical data from two public ART facilities in Makonde District, Zimbabwe. A total of 530 participants (156 cases with VL ≥ 1000 copies/mL and 374 controls) were included. Logistic regression was used to identify independent predictors of high VL. A Naïve Bayes classification model was developed using significant and clinically relevant predictors. Model performance was evaluated on the development dataset, and sensitivity, specificity, predictive values and overall accuracy were calculated. Independent predictors of high VL included being a child (adjusted OR 6.11, 95% CI: 2.12-9.31), adolescent/young adult (AOR 4.69, 95% CI: 1.83-7.54), single/non-partnered marital status (OR 2.01, 95% CI: 1.02-3.04), nondisclosure of HIV status (OR 2.56, 95% CI: 1.48-4.17), ambulatory functional status (OR 3.09, 95% CI 1.64-5.43), recent weight loss on two consecutive visits (OR 4.48, 95% CI: 2.11-8.03, p < 0.001), and ART duration <5 years (OR 1.78, 95% CI 1.15-2.63). The Naïve Bayes model demonstrated a sensitivity of 78.2% and specificity of 96.5%, indicating that the model may miss approximately one in five individuals (22%) with true high viral load, misclassifying them as low risk. The developed Naïve Bayes algorithm shows potential as a risk classification tool to support prioritization of VL testing in resource-limited settings. However, performance estimates represent apparent (development-only) performance and require validation in independent datasets before implementation.

Research topics

  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • HIV-related health complications and treatments

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1371/journal.pgph.0006373

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.